Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco P Schena

Showing results (61-70 of 73) with videos related to

Pageof 8
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 13, 2003
MAGE-6 encodes HLA-DRbeta1*0401-presented epitopes recognized by CD4+ T cells from patients with melanoma or renal cell carcinomaTomohide Tatsumi, Lisa S Kierstead, Elena Ranieri, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 3, 2016
Potential role of effector memory T cells in chronic T cell-mediated kidney graft rejectionClaudia Curci, Fabio Sallustio, Grazia Serino, et al.
Iscience|October 24, 2022
Racial heterogeneity of IgA1 hinge-region <i>O</i>-glycoforms in patients with IgA nephropathyYukako Ohyama, Hisateru Yamaguchi, Soshiro Ogata, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 29, 2021
Association of Treatment Effects on Early Change in Urine Protein and Treatment Effects on GFR Slope in IgA Nephropathy: An Individual Participant Meta-analysisLesley A Inker, Hiddo J L Heerspink, Hocine Tighiouart, et al.
Kidney International|November 19, 2015
In a retrospective international study, circulating miR-148b and let-7b were found to be serum markers for detecting primary IgA nephropathyGrazia Serino, Francesco Pesce, Fabio Sallustio, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 2, 2016
Early Change in Urine Protein as a Surrogate End Point in Studies of IgA Nephropathy: An Individual-Patient Meta-analysisLesley A Inker, Hasi Mondal, Tom Greene, et al.
Clinical Journal of the American Society of Nephrology : CJASN|February 8, 2023
Evaluation of Variation in the Performance of GFR Slope as a Surrogate End Point for Kidney Failure in Clinical Trials that Differ by Severity of CKDWillem Collier, Lesley A Inker, Benjamin Haaland, et al.
Nature Medicine|November 6, 2025
A meta-analysis of albuminuria as a surrogate endpoint for kidney failureHiddo J L Heerspink, Willem H Collier, Juhi Chaudhari, et al.
Journal of the American Society of Nephrology : JASN|March 15, 2023
Change in Albuminuria and GFR Slope as Joint Surrogate End Points for Kidney Failure: Implications for Phase 2 Clinical Trials in CKDHiddo J L Heerspink, Lesley A Inker, Hocine Tighiouart, et al.
Clinical Journal of the American Society of Nephrology : CJASN|April 16, 2025
Clinical Implications of Slope of GFR in Clinical Trials of CKD ProgressionTom Greene, Willem Collier, Benjamin Haaland, et al.
Pageof 8

Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 13, 2003
MAGE-6 encodes HLA-DRbeta1*0401-presented epitopes recognized by CD4+ T cells from patients with melanoma or renal cell carcinomaTomohide Tatsumi, Lisa S Kierstead, Elena Ranieri, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 3, 2016
Potential role of effector memory T cells in chronic T cell-mediated kidney graft rejectionClaudia Curci, Fabio Sallustio, Grazia Serino, et al.
Iscience|October 24, 2022
Racial heterogeneity of IgA1 hinge-region <i>O</i>-glycoforms in patients with IgA nephropathyYukako Ohyama, Hisateru Yamaguchi, Soshiro Ogata, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 29, 2021
Association of Treatment Effects on Early Change in Urine Protein and Treatment Effects on GFR Slope in IgA Nephropathy: An Individual Participant Meta-analysisLesley A Inker, Hiddo J L Heerspink, Hocine Tighiouart, et al.
Kidney International|November 19, 2015
In a retrospective international study, circulating miR-148b and let-7b were found to be serum markers for detecting primary IgA nephropathyGrazia Serino, Francesco Pesce, Fabio Sallustio, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 2, 2016
Early Change in Urine Protein as a Surrogate End Point in Studies of IgA Nephropathy: An Individual-Patient Meta-analysisLesley A Inker, Hasi Mondal, Tom Greene, et al.
Clinical Journal of the American Society of Nephrology : CJASN|February 8, 2023
Evaluation of Variation in the Performance of GFR Slope as a Surrogate End Point for Kidney Failure in Clinical Trials that Differ by Severity of CKDWillem Collier, Lesley A Inker, Benjamin Haaland, et al.
Nature Medicine|November 6, 2025
A meta-analysis of albuminuria as a surrogate endpoint for kidney failureHiddo J L Heerspink, Willem H Collier, Juhi Chaudhari, et al.
Journal of the American Society of Nephrology : JASN|March 15, 2023
Change in Albuminuria and GFR Slope as Joint Surrogate End Points for Kidney Failure: Implications for Phase 2 Clinical Trials in CKDHiddo J L Heerspink, Lesley A Inker, Hocine Tighiouart, et al.
Clinical Journal of the American Society of Nephrology : CJASN|April 16, 2025
Clinical Implications of Slope of GFR in Clinical Trials of CKD ProgressionTom Greene, Willem Collier, Benjamin Haaland, et al.
Pageof 8